ArticleAnnals of hematology2026

Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study.

Anand Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.